During this week’s virtual 2021 Annual Congress of the European Society for Medical Oncology (ESMO), 16-21 September, studies (co) led by VHIO investigators revealed significant advances in the trea...
Read moreCIBER-BBN and VHIR researchers design a new system to transport a drug effective against tumour stem cells, the most resistant ones, through nanoparticles.
Read moreResearch carried out by IDIBELL and ICO within the framework of the European EPIC study, which includes the monitoring of more than 300,000 women for 15 years, has determined the inflammatory potentia...
Read moreAn international study, with the participation of IDIBELL and ICO, determines that the metabolism of breast tumor cells is defined by their origin.
Read moreResearchers at IRB Barcelona identify that the expression of ancestral fragments of viral DNA results in a strong inflammatory response and causes breast tissue dysfunction.
Read moreEl diagnóstico precoz y la mejora de los tratamientos del cáncer de mama han permitido disminuir su mortalidad en los últimos años, llegándose a situar los índices de supervivencia en el 85% a d...
Read moreGenetic inheritance affects the likelihood of developing breast cancer. Some genes are already known to increase cancer risk; other genes are suspected to be involved, but not to what extent. It is cr...
Read moreWith the participation of the Breast Unit of the Arnau de Vilanova University Hospital and IRBLleida
Read moreAmerican Hospital of Paris and OncoDNA announced a new joint initiative that is intended to advance the use of precision medicine in routine clinical practice for patients with metastatic breast cance...
Read moreDenosumab is a fully human monoclonal antibody that binds to, and inhibits, the receptor activator of RANKL (TNFSF11) and might affect breast cancer biology, as shown by preclinical evidence.
Read morePublished in parallel in The New England Journal of Medicine*, data from two phase II studies presented yesterday at the San Antonio Breast Cancer Symposium – SABCS (10 – 14 December, San Anton
Read moreThe new groups, led by researchers Felipe Cortés, Eva González-Suárez and Solip Park, join the more than 400 scientists who make up the Center to boost the basic and translational Molecular Oncolog...
Read more